EV/DNG (Qlaira, BAY86-5027) + Progestin Only Pills
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Contraceptives, Oral
Conditions
Contraceptives, Oral
Trial Timeline
Oct 1, 2010 → Oct 1, 2014
NCT ID
NCT01200186About EV/DNG (Qlaira, BAY86-5027) + Progestin Only Pills
EV/DNG (Qlaira, BAY86-5027) + Progestin Only Pills is a pre-clinical stage product being developed by Bayer for Contraceptives, Oral. The current trial status is completed. This product is registered under clinical trial identifier NCT01200186. Target conditions include Contraceptives, Oral.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01200186 | Pre-clinical | Completed |
Competing Products
4 competing products in Contraceptives, Oral
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AZD1981 + Neovletta 21/28 + Placebo AZD1981 | AstraZeneca | Phase 1 | 33 |
| Leios/Alesse | Pfizer | Pre-clinical | 22 |
| YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) + Yasminelle (SH T 00186 D) | Bayer | Phase 2 | 49 |
| Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2 | Bayer | Phase 1 | 30 |